Prenatal Diagnosis of a Giant Foetal Lymphangioma and Haemangiolymphoma in the Second Trimester Using 2D and 3D Ultrasound

 

 Buy Article Permissions and Reprints

Zusammenfassung

Lymphangiome sind gutartige Tumoren des lymphatischen Systems. Frühzeitige pränatale Diagnostik ist wichtig. Dies erlaubt eine Planung der Geburt, adäquate postpartale Versorgung des Kindes, Verbesserung der Prognose und einen frühzeitigen Schwangerschaftsabbruch im Falle einer ungünstigen Prognose. Wir berichten von 2 Fällen, einem Hämangiolymphangiom und einem Lymphangiom. Die 2D- und 3D-US-Charakteristiken werden präsentiert, die Differenzialdiagnosen, therapeutischen Optionen und die Prognose diskutiert.

Abstract.

Lymphangiomas are benign tumours of the lymphatic system. Early prenatal diagnosis is important to permit a planned delivery and provide adequate postnatal care. It thereby improves prognosis and allows the option of terminating the pregnancy if poor outcome is predicted. We report two cases, a giant haemangiolymphoma and a lymphangioma. 2D and 3D US findings are presented and differential diagnosis, therapeutic options and prognosis are discussed.

References

• 1 Mittermayer C. Lymphangioma/Lymphohaemangioma at 2nd trimester. 4D examination online.  http://www.univie.ac.at/obgyn/prenatale_medizin/3d1.htm. 2002
  Google Scholar
• 2 Lee A, Deutinger J, Bernaschek G. Voluvision: Three-dimensional ultrasonography of foetal malformations.  Am J Obstet Gynecol. 1994;  170 1312-1314
  PubMedGoogle Scholar
• 3 Lee A, Deutinger J, Bernaschek G. Three dimensional ultrasound: abnormalities of the foetal face in surface and volume rendering mode.  Br J Obstet Gynecol. 1995;  102 302-306
  PubMedGoogle Scholar
• 4 Moore K L, Persaud T VN. The cardiovascular system. In: Moore KL, Persaud TVN, eds The Developing Human: Clinical Oriented Embryology.  Philadelphia: W.B: Saunders 1993: 349-351
  Google Scholar
• 5 Fonkalsrude E W. Congenital malformation of the lymphatic system.  Semin Pediatr Surg. 1994;  3 62-69
  PubMedGoogle Scholar
• 6 Allason J E. Lymphatic circulation. In: Stevenson RE, Hall JG, Goodman RS, eds Human Malformation and Related Anomalies.  New York: Oxford University Press 993: 293-304
  Google Scholar
• 7 Benacerraf B R. Syndrmes. In: Benacceraf BR, ed Ultrasound of Foetal Syndroms.  Philadelphia: Churchill Livingston 1998: 343-349
  Google Scholar
• 8 Shah K D, Chervenak F A, Marchevsky A M, Rosenberg J C, Berkovitz R L. Foetal giant haemangiolymphangioma: Report of a case.  Am J Perinatol. 1987;  4 212-214
  PubMedGoogle Scholar
• 9 Giacalone P L, Boulot P, Marty M, Deschmps F, Laffargue F, Viala J l. Foetal haemangiolymphoma: A case report.  Foetal Diagn Therapie. 1993;  8 338-340
  PubMedGoogle Scholar
• 10 Kaminopetros P, Jauniaux E, Weston M, Nicolaides K H, Campell D J. Prenatal diagnosis of an extensive foetal lymphangioma using ultrasonography, magnetic resonance imaging and cytology.  Br J Radiol.. 1997;  70 750-753
  CrossrefPubMedGoogle Scholar
• 11 Romero R, Jeanty P, Ghidini A, Hobbins J. Prenatal Diagnosis of Congenital Anomalies.  Cystic Hygroma.  Norwalk, Connecticut: Appleton Lange 1988
  Google Scholar
• 12 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy in 64 patients with lymphangioma.  J Pediatr Surg. 1994;  29 784-785
  CrossrefPubMedGoogle Scholar
• 13 Ogita S, Tsuto T, Nakamura K, Deguchi E, Iwai N. OK-432 therapy for lymphangiomas in children: why and how does it work?.  J Pediatr Sirg. 1996;  31 477-480
  CrossrefPubMedGoogle Scholar
• 14 Schmidt B, Schimpl G, Hollwarth M E. OK-432 therapy of lymphangiomas in children.  Eu J Pediatr. 1996;  155 649-652
  CrossrefPubMedGoogle Scholar
• 15 Ogita K, Suita S, Taguchi T, Yamanouchi T, Masumoto K, Tsukimori K, Nakano H. Outcome of foetal cystic hygroma and experience of intrauterine treatment.  Foetal Diagn Ther. 2001;  16(2) 105-110
  CrossrefPubMedGoogle Scholar
• 16 Charabi B, Bretlau P, Bille M, Helmelund M. Cystic hygroma of the head and neck - a long-term follow-up of 44 cases.  Acta Otolaryngol Suppl. 2000;  543 248-250
  PubMedGoogle Scholar
• 17 Singh R K, Gutman M, Bucana C D, Sanchez R, Llansa R K, Fidler I J. Interferons α and β downregulate the expression of basic fibroblast growth factor in human carcinomas.  Proc Natl Acad Sci. 1995;  92 4562-4566
  PubMedGoogle Scholar
• 18 Klagsbrun M, D'Amore P A. Regulators of angiogenesis.  Ann Rev Physiol. 1991;  53 217-239
  CrossrefPubMedGoogle Scholar
• 19 White C W, Sondheimer H M, Crouch E C, Wilson H, Fan L L. Treatment of pulmonary haemangiomatosis with recombinant interferon alpha-2a.  N Engl J Med. 1989;  320 1197-1200
  PubMedGoogle Scholar
• 20 Ezekowitz R AB, Mulliken J B, Folkman J. Interferon alpha-2a therapy for life-threatening hemangioma of infancy.  N Engl J Med. 1992;  326 1456-1463
  CrossrefPubMedGoogle Scholar
• 21 Ricketts R R, Hatley R M, Corden B J, Sabio H, Howell C G. Interferon alpha-2a for the treatment of complex haemangiomas of infancy and childhood.  Ann Surg. 1994;  219 605-615
  CrossrefPubMedGoogle Scholar
• 22 Hastings M M, Milot J, Barsoum-Homsy M, Hershon L, Dubois J, Leclerc J M. Recombinant interferon alpha-2a in the treatment of vision-threatening capillary hemangiomas in childhood.  JAAPOS. 1997;  1 226-230
  PubMedGoogle Scholar
• 23 Garmendia G, Miranda N, Borroso S, Longchong M, Martinez E, Ferrero J, Porrero P, Lopez-Saura P. Regression of infancy haemangiomas with recombinant IFN-α2b.  J Interferon Cytokine Res. 2001;  21 31-38
  CrossrefPubMedGoogle Scholar
• 24 Merz E. DEGUM-Standards in Prenatal Level II Ultrasound Diagnosis (18 - 22 weeks of gestation).  Ultraschall in Med. 2001;  22(5) 199
  PubMedGoogle Scholar

MD C. Mittermayer

University Hospital of Vienna · Department of Neonatology and Intensive Care

Währinger Gürtel 18-20 · 1090 Vienna · Austria ·

Phone: +43 1 40400 5572

Fax: +43 1 40400 3296

Email: christoph.mittermayer@gyn.akh.magwien.gv.at